CTT Pharmaceutical CEO & Director Buys 10,900 Shares

What Happened
CTT Pharmaceutical Holdings' CEO and director reported buying 10,900 shares of CTTH on 2026-09-16 at $0.05 per share, for a total cash outlay of approximately $523. The filing lists the transaction as a purchase (code P) described as an open-market or private purchase.

Key Details

• Transaction date: 2026-09-16
• Price per share: $0.05; Shares purchased: 10,900; Total value: ~$523
• Transaction code: P (Purchase); described as open-market or private purchase
• Form filed: 2026-09-16 (no late-filing flag indicated in the supplied data)
• Shares owned after transaction: Not reported in the provided filing details
• No footnotes or 10b5-1 / tax-withholding indications provided

Context
This was a direct purchase of common stock (not an option exercise or award). The dollar amount is very small relative to typical insider transactions, so while insider buys can be a meaningful signal, this particular purchase represents a modest stake and should be weighed accordingly. No motive or trading plan is stated in the filing.